Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Stockholders' Equity (Unaudited)

v3.24.1.u1
Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Retained Earnings (Accumulated Deficit)
Accumulated Other Comprehensive Income (Loss)
Beginning Balance at Dec. 31, 2022 $ 297,406 $ 23 $ 312,126 $ (14,500) $ (243)
Beginning Balance, shares at Dec. 31, 2022   22,941,643      
Stock-based compensation 3,442   3,442    
Employee stock purchases 630   630    
Employee stock purchases, shares   47,676      
Vesting of restricted stock units (454)   (454)    
Vesting of restricted stock units, shares   77,530      
Shares withheld related to net restricted stock settlement (1)   (1)    
Shares withheld related to net restricted stock settlement, shares   (495)      
Stock options exercised 384   384    
Stock options exercised, shares   54,432      
Net loss (20,349)     (20,349)  
Other comprehensive income (loss) 239       239
Ending Balance at Mar. 31, 2023 281,297 $ 23 316,127 (34,849) (4)
Ending Balance, shares at Mar. 31, 2023   23,120,786      
Beginning Balance at Dec. 31, 2023 204,812 $ 23 320,513 (116,949) 1,225
Beginning Balance, shares at Dec. 31, 2023   23,324,750      
Stock-based compensation 2,416   2,416    
Stock issued 370 $ 1 369    
Stock issued, shares   233,927      
Tax withholding related to vesting of restricted stock units (85)   (85)    
Tax withholding related to vesting of restricted stock units, shares   (12,199)      
Net loss (14,578)     (14,578)  
Other comprehensive income (loss) (1,037)       (1,037)
Ending Balance at Mar. 31, 2024 $ 191,898 $ 24 $ 323,213 $ (131,527) $ 188
Ending Balance, shares at Mar. 31, 2024   23,546,478